Navigation Links
Fecal occult blood testing effective in colonoscopy screenings
Date:11/9/2011

Fecal immunochemical testing (FIT) is more effective in its health benefits at the same or lower costs compared to guaiac fecal occult blood testing (gFOBT) at all levels of colonoscopy capacity, according to a study published November 9 by the Journal of the National Cancer Institute.

In many countries, wait times for colonoscopy screenings can take up to 12 weeks. Screening with gFOBT has been proven to reduce mortality from colorectal cancer (CRC); however, the effectiveness of the screening depends partly on attendance at all screening rounds and on diagnostic yield (the proportion of individuals found with adenomas or CRC). FIT may increase attendance and diagnostic yield compared to gFOBT, and may cause fewer false positive tests. Because of these advantages, FIT is of increasing interest in the field.

To determine the benefits of FIT compared with gFOBT, Janneke A. Wilschut, MSc, of the department of public health at the University Medical Center in Rotterdam, the Netherlands, and colleagues used the MISCAN-Colon micro-simulation model, which simulates the relevant biographies of a large population from birth to death both without screening, as well as with changes that would occur in screening programs. The researchers estimated the number of colonoscopies, costs, and health effects of different screening strategies using both gFOBT and FIT, various age ranges and multiple surveillance strategies.

The model predicts that FIT is both cost-effective and clinically beneficial for detecting CRC. They found that for a screening scenario for people ages 45 to 80 years in which there is unlimited colonoscopy capacity, screening intensively with the lowest FIT cutoff level for referral to colonoscopy (50 ng hemoglobin per mL) provided optimal health benefits for cost. For a scenario with limited colonoscopy capacity, FIT with a higher cutoff level performed better than gFOBT and was more effective if the colonoscopy capacity was expanded.

The authors note certain limitations of the study: That they performed only one-way sensitivity analyses to evaluate the impact of other assumptions for some parameters and did not perform a probabilistic sensitivity analysis, stating that because of the large number of strategies needed to evaluate each draw a large computational effort would be required. Nevertheless, they conclude, "It should be noted that FOBT screening can become considerably more effective if colonoscopy capacity is expanded. Efforts should therefore be undertaken to achieve an increased colonoscopy capacity."

In an accompanying editorial, Russell Harris, M.D., MPH, of the Cecil G. Sheps Center for Health Services Research at the University of North Carolina at Chapel Hill and Linda S. Kinsinger, M.D., MPH, of the Department of Health Behavior and Health Education at the University of North Carolina School of Public Health, write that aggressive colonoscopy screening, termed "going the distance," in the United States has potential harms and costs that have not been fully explored. They discuss that the use of simulation models, such as the one described by Wilschut et al., could be useful to make real-world decisions about how intensive screening should be under different colonoscopy capacities by measuring clinical and cost effectiveness. However, such models do not incorporate the potential harms of aggressive screening programs, such as patient anxiety, the discomfort and inconvenience of the colonoscopy bowel preparation, sedation effects, loss of productivity at work and home, overdiagnosis, and the risk of complications from a biopsy and polypectomy, or take into account a situation in which resources are limited. Harris and Kinsinger suggest that outcomes tables are needed in addition to a simulation model to fully compare the benefits, harms, and costs of screening strategies. They suggest that such an analysis might reveal that a primary colonoscopy screening strategy ("going the distance"), as currently practiced in the US, provides less health value at higher cost than a strategy of restricting colonoscopic screening to smaller subgroups. In conclusion, "If not going the distance means fewer harms to patients, more participation by under-screened groups, fewer opportunity costs to the health-care system and lower overall cost for CRC screening, then less colonoscopy can mean more well-being for us all."


'/>"/>

Contact: Zack Rathner
Zachary.Rathner@oup.com
301-841-1286
Journal of the National Cancer Institute
Source:Eurekalert

Related medicine news :

1. Noninvasive fecal occult blood test effective screen for lower GI tract lesions
2. 1 in 6 Cellphones in Britain Contaminated With Fecal Matter
3. Fecal Transplants Show Promise for Gastrointestinal Ills
4. Inflammatory Bowel Ups Risk for Blood Clots
5. Bowel disease link to blood clots
6. Local Blood Supply Impacted by Wednesdays Severe Snow Storm
7. PERSONALABS Offers Discounted Healthy Heart Online Blood Tests in February
8. China Cord Blood Corporation Warrant Registration Statement Declared Effective by SEC
9. NIH grants to Childrens Hospital will advance novel stem cell treatments for blood disorders
10. Bilberry Seems to Act Against Blood Sugar
11. Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... On June ... sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, ... of the city’s history as home to some of the world’s leading providers of ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
(Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, 2016 ... mobile pulmonary function testing company, is now able to perform sophisticated ... by ndd Medical Technologies , Inc. Patients ... hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients ... get any needed testing done in the comfort of her own ...
Breaking Medicine Technology: